COVID-19 Misleading Advertising Campaign Lawsuit Against Pfizer Challenges PREP Act Liability Shield
A United States district judge has remanded a lawsuit filed by the state of Kansas against Pfizer, Inc. back to state court. This move may prevent the Public Readiness and Preparedness (PREP) Act from shielding the pharmaceutical giant from liability for Its misleading advertising campaign promoting its mRNA COVID-19 shot (Comirnaty).1 The Kansas attorney general, […]
Meningitis B Vaccine to Be Used for Gonorrhea in England
In August 2025, England will become the first country to offer a vaccine for gonorrhea after cases exceed 85,000 in 2023—the highest gonorrhea levels since recordkeeping began in 1918. The program, offered through the United Kingdom’s National Health Service (NHS), will repurpose the meningitis B vaccine, routinely given to infants, in an attempt to reduce […]
Media Blatantly Misinforms the Public on COVID Vaccination
In a video post on the social media platform X on May 27, 2025, U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. stated: The COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule. Last year, the Biden administration urged healthy children to […]
Senate Homeland Security Committee’s Hearing on Adverse Events Related to COVID-19 Vaccines
The topic today is myocarditis, or heart damage, from the COVID-19 vaccines. I’ve examined thousands of patients with this problem, thousands. Before the pandemic, I had two patients ever with this problem. There’s 1,065 papers in the peer review literature on COVID vaccine myocarditis. … This is not misinformation. Everyone should be paying attention to […]
FDA Approves Novavax’s COVID-19 Vaccine With Restrictions
On May 16, 2025, the U.S. Food and Drug Administration (FDA) approved licensure of Novavax, Inc.’s Nuvaxovid protein-based COVID-19 vaccine, which has been available in the United States under Emergency Use Authorization (EUA) since July 2022.1 The decision for a full licensure was postponed while the new agency leadership under the current administration conducted a […]
ACIP Considers Changes to HPV Vaccine Recommendations
The U.S. Centers for Disease Control and Prevention’s (CDC) current universal use recommendation for the HPV (human papillomavirus) vaccine is two doses given to adolescent by ages 11-12 and three doses if the series is started on or after age 15. The vaccine can be given to children as young as age nine, but that […]